Influence of marrow erythropoietic activity on serum erythropoietin levels after autologous hematopoietic stem cell transplantation

Haematologica

Volumn 83, Issue 12, 1998, Pages 1076-1081

  Beguin, Yves ^a   Baron, Frédéric ^a   Fillet, Georges ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Erythropoiesis; Hematopoietic stem cell transplantation; Serum erythropoietin; Soluble transferrin receptor

Indexed keywords

ERYTHROPOIETIN; TRANSFERRIN RECEPTOR;

ADOLESCENT; ADULT; ANEMIA; ARTICLE; AUTOTRANSPLANTATION; CHILD; CLINICAL ARTICLE; ERYTHROPOIESIS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HORMONE BLOOD LEVEL; HUMAN; HYPOXIA; MALE; TISSUE OXYGENATION;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CHILD; ERYTHROPOIESIS; ERYTHROPOIETIN; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; TRANSPLANTATION, AUTOLOGOUS;

EID: 0032411559     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Caro J, Beck I, Ramirez S, Costa Giomi P, Schuster SJ. Regulation of erythropoietin gene expression. Semin Hematol 1991; 28:42-5.
2. Eckardt K-U, Bauer C. Erythropoietin in health and disease. Eur J Clin Invest 1989; 19:117-27.
3. Jelkmann W. Erythropoietin: structure, control of production, and function. Physiol Rev 1992; 72:449-89.
4. Porter DL, Goldberg MA. Regulation of erythropoietin production. Exp Hematol 1993; 21:399-404.
5. Erslev AJ. Erythropoietin titers in health and disease. Semin Hematol 1991; 28:2-7.
6. Erslev AJ. Erythropoietin. N Engl J Med 1991; 324: 1339-44.
7. Beguin Y, Clemons G, Pootrakul P, Fillet G. Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin. Blood 1993; 81:1067-76.
8. Urabe A, Mitani K, Yoshinaga K, et al. Serum erythropoietin titers in hematological malignancies and related diseases. Int J Cell Cloning 1992; 10:333-7.
9. Gaines Das RE, Milne A, Rowley M, Smith EC, Cotes PM. Serum immunoreactive erythropoietin in patients with idiopathic aplastic and Fanconi's anaemias. Br J Haematol 1992; 82:601-7.
10. Schrezenmeier H, Noe G, Raghavachar A, Rich IN, Heimpel H, Kubanek B. Serum erythropoietin and serum transferrin receptor levels in aplastic anaemia. Br J Haematol 1994; 88:286-94.
11. Cazzola M, Guarnone R, Cerani P, Centenara E, Rovati A, Beguin Y. Red cell precursor mass as an independent determinant of serum erythropoietin level. Blood 1998; 91:2139-45.
12. Kendall RG, Cavill I, Norfolk DR. Serum erythropoietin levels during haematinic therapy. Br J Haematol 1992; 81:630-1.
13. Cazzola M, Beguin Y. New tools for clinical evaluation of erythron function in man. Br J Haematol 1992; 80:278-84.
14. Piroso E, Erslev AJ, Caro J. Inappropriate increase in erythropoietin titers during chemotherapy. Am J Hematol 1989; 32:248-54.
15. Birgegard G, Wide L, Simonsson B. Marked erythropoietin increase before fall in Hb after treatment with cytostatic drugs suggests mechanism other than anaemia for stimulation. Br J Haematol 1989; 72:462-6.
16. Abedi MR, Backman L, Bostrom L, Lindback B, Ringden O. Markedly increased serum erythropoietin levels following conditioning for allogeneic bone marrow transplantation. Bone Marrow Transplant 1990; 6:121-6.
17. Grace RJ, Kendall RG, Chapman C, Hartley AE, Barnard DL, Norfolk DR. Changes in serum erythropoietin levels during allogeneic bone marrow transplantation. Eur J Haematol 1991; 47:81-5.
18. Ireland RM, Atkinson K, Concannon A, Dodds A, Downs K, Biggs JC. Serum erythropoietin changes in autologous and allogeneic bone marrow transplant patients. Br J Haematol 1990; 76:128-34.
19. Lazarus HM, Goodnough LT, Goldwasser E, Long G, Arnold JL, Strohl KP. Serum erythropoietin levels and blood component therapy after autologous bone marrow transplantation: implications for erythropoietin therapy in this setting. Bone Marrow Transplant 1992; 10:71-5.
20. Schapira L, Antin JH, Ransil BJ, et al. Serum erythropoietin levels in patients receiving intensive chemotherapy and radiotherapy. Blood 1990; 76:2354-9.
21. Miller CB, Jones RJ, Zahurak ML, et al. Impaired erythropoietin response to anemia after bone marrow transplantation. Blood 1992; 80:2677-82.
22. Bosi A, Vannucchi AM, Grossi A, et al. Inadequate erythropoietin production in allogeneic bone marrow transplant patients. Haematologica 1991; 76:280-4.
23. Bosi A, Vannucchi AM, Grossi A, et al. Serum erythropoietin levels in patients undergoing autologous bone marrow transplantation. Bone Marrow Transplant 1991; 7:421-5.
24. Beguin Y, Clemons GK, Oris R, Fillet G. Circulating erythropoietin levels after bone marrow transplantation: Inappropriate response to anemia in allogeneic transplants. Blood 1991; 77:868-73.
25. Beguin Y, Oris R, Fillet G. Dynamics of erythropoietic recovery after bone marrow transplantation: role of marrow proliferative capacity and erythropoietin production in autologous versus allogeneic transplants. Bone Marrow Transplant 1993; 11:285-92.
26. Vannucchi AM, Grossi A, Bosi A, et al. Impaired erythropoietin production in mice treated with cyclosporin A. Blood 1991; 78:1615-8.
27. Vannucchi AM, Grossi A, Bosi A, et al. Effects of cyclosporin A on erythropoietin production by the human Hep3B hepatoma cell line. Blood 1993; 82:978-84.
28. Lee LG, Chen CH, Chiu LA. Thiazole orange: a new dye for reticulocyte analysis. Cytometry 1986; 7:508-17.
29. Huebers HA, Beguin Y, Pootrakul P, Einspahr D, Finch CA. Intact transferrin receptors in human plasma and their relation to erythropoiesis. Blood 1990; 75:102-7.
30. Barosi G. Inadequate erythropoietin response to anemia: definition and clinical relevance. Ann Hematol 1994; 68:215-23.
31. Caro J, Brown S, Miller O, Murray T, Erslev AJ. Erythropoietin levels in uremic nephric and anephric patients. J Lab Clin Med 1979; 93:449-58.
32. Means RT Jr, Krantz SB. Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 1992; 80:1639-47.
33. Beguin Y. Erythropoietin and the anemia of cancer. Acta Clin Belg 1996; 51:36-52.
34. Cotes PM, Doré CJ, Liu Yin JA, et al. Determination of serum immunoreactive erythropoietin in the investigation of erythrocytosis. N Engl J Med 1986; 315:283-7.
35. Fisher JW, Roh BL. Influence of alkylating agents on kidney erythropoietin production. Cancer Res 1964; 24:983-8.
36. Wolff M, Jelkmann W. Effects of chemotherapeutic and immunosuppressive drugs on the production of erythropoietin in human hepatoma cultures. Ann Hematol 1993; 66:27-31.
37. Jelkmann W, Wolff M, Fandrey J. Inhibition of erythropoietin production by cytokines and chemotherapy may contribute to the anemia in malignant diseases. Adv Exp Med Biol 1994; 345:525-30.
38. Youssoufian H, Longmore G, Neumann D, Yoshimura A, Lodish HF. Structure, function, and activation of the erythropoietin receptor. Blood 1993; 81:2223-36.
39. Bowen DT, Janowska-Wieczorek A. Serum erythropoietin following cytostatic therapy [letter]. Br J Haematol 1990; 74:372-3.
40. Stohlman F Jr, Brecher G. Humoral regulation of erythropoiesis. V. Relationship of plasma erythropoietin level to bone marrow activity. Proc Soc Exp Biol Med 1959; 100:40-3.
41. Naets JP, Wittek M. Effect of erythroid hypoplasia on utilization of erythropoietin. Nature 1965; 206:726-7.
42. Bozzini CE. Influence of erythroid activity of the bone marrow on the plasma disappearance of injected erythropoietin in dogs. Nature 1966; 209:1140-1.
43. Pick CG, Statter M, Ben-Shachar D, Youdim MB, Yanai J. Normal zinc and iron concentrations in mice after early exposure to phenobarbital. Int J Dev Neurosci 1987; 5:391-8.
44. Piroso E, Erslev AJ, Flaharty KK, Caro J. Erythropoietin life span in rats with hypoplastic and hyperplastic bone marrows. Am J Hematol 1991; 36:105-10.
45. Kampf D, Eckardt KU, Fischer HC, Schmalisch C, Ehmer B, Schostak M. Pharmacokinetics of recombinant human erythropoietin in dialysis patients after single and multiple subcutaneous administrations. Nephron 1992; 61:393-8.
46. Lezon C, Alippi RM, Barcelo AC, Martinez MP, Conti MI, Bozzini CE. Depression of stimulated erythropoietin production in mice with enhanced erythropoiesis. Haematologica 1995; 80:491-4.
47. Bergamaschi G, Recalde HH, Ponchio L, Rosti V, Cazzola M. Erythrophagocytosis increases the expression of erythroid potentiating activity mRNA in human monocyte-macrophages. Exp Hematol 1993; 21:70-3.
48. Erslev AJ. The effect of hemolysates on red cell production and erythropoietin release. J Lab Clin Med 1971; 78:1-7.